Codexis weighs into generics biz via India
Codexis is using India as a springboard to launch it into direct sales of high-value generic pharmaceutical intermediates, to be sold into unregulated markets for use in patented drugs.
Codexis is using India as a springboard to launch it into direct sales of high-value generic pharmaceutical intermediates, to be sold into unregulated markets for use in patented drugs.
Rhodia was present at this year's CPhI, alerting the industry to its latest product updates, spawned out of the market demand to provide products that allow its customers to better address process and handling requirements.
In its ambition to become one of the top three global players in custom manufacturing, the UK subsidiary of drug-maker Nicholas Piramal (NPIL) has created a new "innovation unit" in Europe.
Filter maker Pall Corporation has announced its plan to invest about $50m (€63.5m) to expand its life sciences manufacturing operations in Puerto Rico and take advantage the island's low tax regime.